Retinal Toxicity of Commercial Tissue Plasminogen Activator Is Mediated by the Induction of Nitric Oxide in the Mouse Retinal Primary Cells

REFERENCES

• Pennica D, Holmes W E, Kohr W J, Harkins R N, Vehar G A, Ward C A, Bennett W F, Yelverton E, Seeburg P H, Heyneker H L, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature. 1983; 301: 214–221, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Collen D, Stassen J M, Marafino B J, Jr, Builder S, De Cock F, Ogez J, Tajiri D, Pennica D, Bennett W F, Salwa J, et al. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther. 1984; 231: 146–152, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hoylaerts M, Rijken D C, Lijnen H R, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem. 1982; 257: 2912–2919, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tiefenbrunn A J, Robinson A K, Kurnik P B, Ludbrook P A, Sobel B E. Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology. Circulation. 1985; 71: 110–116, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Agnelli G, Buchanan M R, Fernandez F, Boneu B, Van Ryn J, Hirsh J, Collen D. A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. Circulation. 1985; 72: 178–182, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hassan A S, Johnson M W, Schneiderman T E, Regillo C D, Tornambe P E, Poliner L S, Blodi B A, Elner S G. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999; 106: 1900–1907, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hattenbach L O, Klais C, Koch F H, Gumbel H O. Intravitrous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. 2001; 108: 1485–1492, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Peyman G A, Nelson N C, Alturki W, Blinder K J, Paris C L, Desai U R, Harper C A. Tissue plasminogen activating factor assisted removal or subretinal hemorrhage. Ophthalmic Surg. 1991; 22: 575–582, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal or submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996; 121: 267–275, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lewis H, Medendorp S V. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial. Ophthalmology. 1997; 104: 1847–1850, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Haupert C L, McCuen B W, Jaffe G J, Steuer E R, Cox T A, Toth C A, Fekrat S, Postel E A. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. 2001; 131: 208–215, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hrach C J, Johnson M W, Hassan A S, Lei B, Sieving P A, Elner V M. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol. 2000; 118: 659–663, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Johnson M W, Olsen K R, Hernandez E, Irvine W D, Johnson R N. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol. 1990; 108: 259–263, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Irvine W D, Johnson M W, Hernandez E, Olsen K R. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol. 1991; 109: 718–722, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Chen S N, Yang T C, Ho C L, Kuo Y H, Yip Y, Chao A N. Retinal toxicity of intravitreal tissue plasminogen activator. Ophthalmology. 2003; 110: 704–708, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Loewenstein A, Zemel E, Lazar M, Perlman I. Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam. Invest Ophthalmol Vis Sci. 1993; 34: 3466–3476, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Koh J Y, Choi D W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 1987; 20: 83–90, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sakurai S, Kamachi K, Konda T, Miyajima N, Kohase M, Yamamoto S. Nitric oxide induction by pertussis toxin in mouse spleen cells via gamma interferon. Infect Immunol. 1996; 64: 1309–1313, [CSA]
   PubMed Web of Science ®Google Scholar
• Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J, Yamabe K, Otsuki Y, Matsuda H, Tsujimoto Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 1996; 56: 2161–2166, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. 1999; 237: 273–277, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer R M, Higgs E A. Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol. 1989; 38: 1709–1715, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer R M. Biosynthesis and actions of nitric oxide. Semin Perinatol. 1991; 15: 16–19, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kurenny D E, Moroz L L, Turner R W, Sharkey K A, Barnes S. Modulation of ion channels in rod photoreceptors by nitric oxide. Neuron. 1994; 13: 315–324, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bredt D S, Hwang P M, Snyder S H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990; 347: 768–770, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Goureau O, Lepoivre M, Becquet F, Courtois Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proc Natl Acad Sci USA. 1993; 90: 4276–4280, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yamamoto R, Bredt D S, Dawson T M, Snyder S H, Stone R A. Enhanced expression of nitric oxide synthase by rat retina following pterygopalatine parasympathetic denervation. Brain Res. 1993; 631: 83–88, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cui Q, Harvey A R. At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. J Neurosci. 1995; 15: 8143–8155, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Koeberle P D, Ball A K. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Exp Neurol. 1999; 158: 366–381, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Goureau O, Regnier-Ricard F, Desire L, Courtois Y. Role of nitric oxide in photoreceptor survival in embryonic chick retinal cell culture. J Neurosci Res. 1999; 55: 423–431, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kim K Y, Moon J I, Lee E J, Lee Y J, Kim I B, Park C K, Oh S J, Chun M H. The effect of L-arginine, a nitric oxide synthase substrate, on retinal cell proliferation in the postnatal rat. Dev Neurosci. 2002; 24: 313–321, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ju W K, Kim K Y, Park S J, Park D K, Park C B, Oh S J, Chung J W, Chun M H. Nitric oxide is involved in sustained and delayed cell death of rat retina following transient ischemia. Brain Res. 2000; 881: 231–236, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Oku H, Yamaguchi H, Sugiyama T, Kojima S, Ota M, Azuma I. Retinal toxicity of nitric oxide released by administration of a nitric oxide donor in the albino rabbit. Invest Ophthalmol Vis Sci. 1997; 38: 2540–2544, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Takahata K, Katsuki H, Kume T, Nakata D, Ito K, Muraoka S, Yoneda F, Kashii S, Honda Y, Akaike A. Retinal neuronal death induced by intraocular administration of a nitric oxide donor and its rescue by neurotrophic factors in rats. Invest Ophthalmol Vis Sci. 2003; 44: 1760–1766, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar